FDA
-
-
-
-
-
-
-
Medivir partner Infex Therapeutics receives FDA QIDP designation
-
-
-
-
-
-
-
The Transformation Into a Company Focused on Clinical Development of Pharmaceuticals has now been Completed and Medivir Gives a Project Update
-
-
-
-
-
-
-
FDA Accepts Medivir“s IND Application for MIV-711, Enabling Clinical Development in the US
-
330,686 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

